多尼培南中间体
(2S,4R)-2-(hydroxymethyl)-4-[(methylsulfonyl)oxy]-1-Pyrrolidinecarboxylic acid,(4-nitrophenyl)methyl ester (Doripenem side-chain intermediate); 4-Nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino]methyl]pyrrolidine-1-carboxylate (Doripenem side-chain)
北京 更新日期：2023-05-15
产品详情:
- 中文名称：
- 多尼培南中间体
- 英文名称：
- (2S,4R)-2-(hydroxymethyl)-4-[(methylsulfonyl)oxy]-1-Pyrrolidinecarboxylic acid,(4-nitrophenyl)methyl ester (Doripenem side-chain intermediate); 4-Nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino]methyl]pyrrolidine-1-carboxylate (Doripenem side-chain)
- CAS号：
- 127626-37-3; 491878-06-9
公司简介
Established in 2000, Beijing Lunarsun Pharmaceutical Co., Ltd is an emerging specialized pharmaceutical company with the head office located in Beijing. Lunarsun Pharma comprises of one new-drug research institute in Beijing (Beijing Saintsun Pharmaceutical Institute), two chemical factories in Jiangsu Province (Jiangsu Chemstar Industrials Co., Ltd.) and Hebei province and one GMP production base in Chongqing (Chongqing Lummy Pharmaceutical Co., Ltd.).
| 成立日期 | |
| 注册资本 | |
| 员工人数 | |
| 年营业额 | |
| 经营模式 | |
| 主营行业 |
